No be joke o! GSK, the British pharmaceutical giant don report sharp rise for their net profit wey dem make last year. Na strong sales from HIV, respiratory, and cancer drugs help dem recover from some wahala dem face over their Zantac heartburn drug. As e dey be, profit after tax don climb reach £5.7 billion ($7.8 billion) compared to the £2.6 billion wey dem make in 2024. Na wetin GSK talk for their statement.
Luke Miels wey just take over as CEO from Emma Walmsley for January, don yan say, “GSK deliver another strong performance for 2025, driven mainly by Speciality Medicines.” E even talk say dem expect this good vibe to continue for 2026. Na so the big man shade us some better gist!
As dem dey plan the year ahead, GSK dey forecast low double-digit increase for their speciality medicines, but e get some matter wey dey ground as dem dey expect decline for revenue wey come from vaccines and general medicines. But no worry, shares for GSK don dey up around two percent since morning wey London Stock Exchange open, as FTSE 100 index self dey shine well well.
Last year, GSK see better earnings compared to 2024 when dem agree say dem go pay $2.3 billion to close matter of lawsuits wey dey claim say Zantac fit cause cancer, but dem no admit say dem do anything wrong. The pharmaceutical industry self dey face gbaladun from all these wahala wey dey come from the United States especially from Trump wey dey throw tariffs like say dem dey throw party balloon.
GSK join several other big pharmaceutical companies last December to reduce price of prescription medicines for American patients so that dem fit enjoy some tariff exemptions for three years. No forget say more than half of GSK total revenue last year come from United States. Na real wahala be that o!
Wet in you dey wait for? If you fit grab opportunity to invest for premium domains wey fit give you profit like #17-#25 million from just #2.5 million, why you no go do am? Abeg, no carry your eyes close for this chance wey dey shine for ground!
Do you have a news tip for NNN? Please email us at editor @ nnn.ng
